[The rheumatologist's conflict between "off-label" prescription and failure to render assistance]

Z Rheumatol. 2003 Feb;62(1):34-5. doi: 10.1007/s00393-003-0491-1.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / economics
  • Arthritis, Rheumatoid / drug therapy*
  • Cost-Benefit Analysis
  • Disease Progression
  • Drug Approval / legislation & jurisprudence*
  • Drug Costs / legislation & jurisprudence
  • Drug Therapy, Combination
  • Ethics, Medical*
  • Germany
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / economics
  • Insurance Coverage / economics
  • Insurance Coverage / legislation & jurisprudence*
  • Insurance, Pharmaceutical Services / economics
  • Insurance, Pharmaceutical Services / legislation & jurisprudence*
  • Male
  • Methotrexate / administration & dosage*
  • Methotrexate / economics
  • Middle Aged
  • Mycophenolic Acid / administration & dosage*
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / economics
  • National Health Programs / economics
  • National Health Programs / legislation & jurisprudence*
  • Refusal to Treat / legislation & jurisprudence*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Methotrexate